Foundayo Pill Offers New Daily Option for Weight Loss

Health Points

• Foundayo is a once-daily oral GLP-1 receptor agonist that can be taken with or without food.
• It is approved for adults managing obesity or weight-related conditions alongside diet and exercise.
• Commercial insurance may lower the cost to $25 per month, with self-pay pricing at $149.

Federal regulators recently approved Foundayo, a new daily pill that offers an alternative to injectable weight loss medications. It is the second oral option in the GLP-1 class.

The treatment is designed for adults managing obesity or those overweight with weight-related conditions when paired with diet and exercise. Clinical trials showed significant results, with high-dose participants losing an average of 27 pounds over 72 days.

The FDA used a fast-track program to expedite the approval amid growing demand for accessible obesity treatments. Experts say the pill is easier for travel and daily routines, but long-term data is still being gathered.

It also carries potential side effects, including nausea and a boxed warning for specific tumors.

“It’s a significant milestone to have another GLP-1 tablet,” said Dr. Pouya Shafipour, a family and obesity medicine physician.

Medical professionals emphasize that sustainable health still depends on protein, fiber, regular physical activity, and other healthy habits.

For more information on the latest weight loss treatments and wellness strategies, consult with your healthcare provider to determine the best approach for your health journey.